Contract Manufacturing, Solid Dosage

Cambrex to Acquire Halo Pharma for $425 Million

July 23, 2018

The acquisition will place Cambrex into the finished dosage form CDMO market.

Addressing Continuous Manufacturing’s Growing Pains

May 16, 2018

Equipment and Processing Report

As more continuous processes move toward commercialization, users and equipment vendors are working to speed changeovers and address other needs.

Lonza Expands Encapsulation and HPAPI Capabilities in North America

February 20, 2018

A new suite for the encapsulation of highly potent drugs will be added.

Recipharm Reveals Plans to Discontinue Operations in Two Swedish Facilities

November 10, 2017

As part of Recipharm’s ongoing initiative to improve profitability and competitiveness, a decision has been made to end operations in Stockholm and Höganäs.

CDMO Acquisitions Build Strategic Supplier Base

November 02, 2017

Recent acquisitions are creating CDMOs with scale that rivals global bio/pharma.

CordenPharma Invests in Small Molecule API Development Capacity

October 17, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

CordenPharma will expand development capacity for small molecules, peptides, and carbohydrates at its Liestal, Switzerland site

CPhI Annual Report Highlights Unpredictability in CDMO Growth Over Next Five Years

October 13, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

Predicted areas of growth include flow chemistry, fermentation, repatriation of overseas funds, oncology, and API/product integration, but the rate of change is unclear.

Up and Away, M&A

October 02, 2017

Mergers and acquisitions are positive for the CDMO industry, but there is a downside.

Cambrex Adds Reactors to Facility in Sweden

September 26, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

Additional reactor capacity and a wastewater processing plant increase API manufacturing capacity at the Cambrex site in Kalskoga, Sweden.

Catalent Adds Early Development Offerings to OptiForm Platform

July 18, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

Catalent expands the scope of the OptiForm Solution Suite to bridge gap from late-stage discovery to Phase I trials.